← Back to Clinical Trials
Recruiting NCT07119840

NCT07119840 Comparison Of Clinical Effects Of Listerine And Chlorhexidine Mouth Wash In Patients Undergoing Fixed Orthodontic Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07119840
Status Recruiting
Phase
Sponsor Khyber Medical University Peshawar
Condition Gingivitis
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-08-01
Primary Completion 2025-11-29

Eligibility & Interventions

Sex All sexes
Min Age 13 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Listerine Mouthwash ProductChlorhexidine mouthwash

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-08-01 with a primary completion date of 2025-11-29.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized clinical trial aims to compare the effectiveness of Listerine and Chlorhexidine mouthwashes in improving periodontal health in patients undergoing fixed orthodontic treatment. Gingival Index and Plaque Index will be assessed at baseline, 2 weeks, and 4 weeks.

Eligibility Criteria

Inclusion Criteria: * Aged 13-40 years * Permanent dentition (including first molars) * Willing to undergo orthodontic treatment and follow instructions Exclusion Criteria: * Systemic illness (e.g., diabetes, heart disease, hepatitis) * Pregnant/lactating females * Tobacco use * History of allergies to mouthwash/toothpaste * Use of mouthwash in past 3 months * Abnormal oral morphology or parafunctional habits

Contact & Investigator

Central Contact

Fazli Rabi, MPH*

✉ fazlirabi804@gmail.com

📞 +92 307 5663219

Principal Investigator

Fazli Rabi, MPH*

PRINCIPAL INVESTIGATOR

Khyber Medical University

Frequently Asked Questions

Who can join the NCT07119840 clinical trial?

This trial is open to participants of all sexes, aged 13 Years or older, up to 40 Years, studying Gingivitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07119840 currently recruiting?

Yes, NCT07119840 is actively recruiting participants. Contact the research team at fazlirabi804@gmail.com for enrollment information.

Where is the NCT07119840 trial being conducted?

This trial is being conducted at Swāt, Pakistan.

Who is sponsoring the NCT07119840 clinical trial?

NCT07119840 is sponsored by Khyber Medical University Peshawar. The principal investigator is Fazli Rabi, MPH* at Khyber Medical University. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology